Next Article in Journal
Comprehensive Evaluation of Genome Gap-Filling Tools Utilizing Long Reads
Previous Article in Journal
A Study of Polish Family with Scoliosis and Limb Contractures Expands the MYH3 Disease Spectrum
Previous Article in Special Issue
Notch Signaling Regulates Mouse Perivascular Adipose Tissue Function via Mitochondrial Pathways
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Pericytes as the Orchestrators of Vasculature and Adipogenesis

by
Caroline de Carvalho Picoli
1,
Alexander Birbrair
2 and
Ziru Li
1,*
1
Center for Molecular Medicine, MaineHealth Institute for Research, Scarborough, ME 04074, USA
2
Department of Dermatology, University of Wisconsin-Madison, Medical Sciences Center, Madison, WI 53706, USA
*
Author to whom correspondence should be addressed.
Genes 2024, 15(1), 126; https://doi.org/10.3390/genes15010126
Submission received: 19 December 2023 / Revised: 17 January 2024 / Accepted: 18 January 2024 / Published: 19 January 2024
(This article belongs to the Special Issue Cellular and Developmental Biology of Lipid Metabolism)

Abstract

:
Pericytes (PCs) are located surrounding the walls of small blood vessels, particularly capillaries and microvessels. In addition to their functions in maintaining vascular integrity, participating in angiogenesis, and regulating blood flow, PCs also serve as a reservoir for multi-potent stem/progenitor cells in white, brown, beige, and bone marrow adipose tissues. Due to the complex nature of this cell population, the identification and characterization of PCs has been challenging. A comprehensive understanding of the heterogeneity of PCs may enhance their potential as therapeutic targets for metabolic syndromes or bone-related diseases. This mini-review summarizes multiple PC markers commonly employed in lineage-tracing studies, with an emphasis on their contribution to adipogenesis and functions in different adipose depots under diverse metabolic conditions.

1. Introduction

Pericytes (PCs) were initially described in the 19th century by Charles-Marie Benjamin Rouget, who observed a population of contractile cells in small blood vessels, and designated them Rouget cells [1]. In the 20th century, Karl Wilhelm Zimmermann renamed these cells “pericytes”, due to their distinct anatomical position around the vasculature [2]. Characterized by long cytoplasmic processes around blood vessel walls [3], PCs communicate with endothelial cells through physical contact or through secreting paracrine signals [4]. Adipose tissues are well vascularized and harbor a significant population of PCs [5] (Figure 1); understanding the functions of these cells and their connections with vascular cells and adipocytes, as well as their effects on adipogenesis, may provide a promising opportunity for therapeutic intervention in metabolic diseases, such as obesity and type 2 diabetes.
Although advances have been made in understanding the effects of PCs on adipose tissue homeostasis, ongoing debates persist on this subject. A primary challenge is that PCs are very heterogeneous, which complicates the characterization of this cell population due to the absence of distinct cell-specific markers. Furthermore, PCs have been implicated in diverse physiological processes, including angiogenesis, tissue regeneration, and adipocyte differentiation, all of which are still under active investigation. Hence, this review will summarize the most recent insights about PC markers based on the lineage tracing studies, and PC functions in adipose tissues, such as white (WAT), brown (BAT), beige and bone marrow (BMAT) adipose tissues.

2. Literature Search Strategy

To provide a comprehensive overview of the current state of knowledge regarding the topic of PCs in adipose tissue, relevant papers were chosen from prominent databases, including PubMed/MEDLINE, Google Scholar, Scopus, and Web of Science, covering the past 30 years. An exception was made for the historical review of PCs, extending over 150 years ago. The following search keywords were used: “Pericytes” OR “perivascular cells” AND “adipose tissue” OR “adipocytes” OR “adipogenesis” OR “fat”. Data in each selected paper was carefully reviewed to provide a precise and comprehensive overview of the key aspects of PCs, particularly their contribution and functions in different adipose tissues.

3. The Hallmarks of Pericytes: Insights from Lineage-Tracing Studies

It has been challenging to define PCs by a particular molecular marker due to the fact that PC subtypes vary across tissues [6,7,8,9], coupled with differences in the characteristics, functions, and locations of this cell population in a tissue-dependent manner [10]. For example, platelet-derived growth factor receptor-beta (PDGFRβ) [11,12,13,14,15], nerve/glial antigen 2 (NG2, also known as chondroitin sulfate proteoglycan 4, CSPG4) [12,16,17], clusters of differentiation 146 (CD146) [12,18,19,20,21,22], T-box18 (TBX18) [15], α-smooth muscle actin (α-SMA) [10,23], and NESTIN [24,25] are commonly used as PC markers in most of the tissues. However, other tissue-specific markers were also proposed by a single-cell transcriptome analytic study: such as Kcnk3 in the lung, Rgs4 in the heart, myosin heavy chain 11 (Myh11) and Knca5 in the kidney, Pcp4l1 in the bladder, and Higd1b in the lung and the heart [26].
In addition to the tissue-specific manner, the identification of PCs varies between species. For example, CD105, CD13 [27], and CD73 [28] were used as PC markers in human studies, while smooth muscle myosin [29], tropomyosin [29], vimentin [30], desmin [10,30], connexin 43 (Cx43) [31], Endosialin (CD248) [32,33], γ-glutamyl transpeptidase (GGT) [34], protein kinase G (PKG) [35], aminopeptidase A (APA) [36], a regulator of G protein signaling 5 (RGS5) [37,38], ATP-sensitive potassium Kir6.1 [39,40], sulfonylurea receptor 2 (SUR2) [41], and delta-like 1 homolog (DLK1) [42,43] were identified in mouse PCs.
However, one of the caveats of these markers is that they are also expressed, to some extent, in other cell types, such as smooth muscle and interstitial cells [44,45,46]. Thus, few dynamic molecular markers could be commonly used in PC identification, with expression varying in a tissue-specific manner or depending on the developmental stages or type of blood vessels. Nevertheless, several PC markers, including PDGFRβ, NG2, TBX18, SMA, NESTIN, and CD146, have been used for PC profiling and lineage-tracing studies to identify the involvement of PCs in adipocyte differentiation. We will summarize the contribution of these PCs labelled by different markers in WAT and BAT under different metabolic or environmental conditions (Table 1).
PDGFRβ—Using a pulse-chase lineage-tracing approach, Shao et al. found that PDGFRβ+ preadipocytes contribute to gonadal and perirenal WAT expansion upon high-fat diet feeding, but not in inguinal WAT [51]. In addition, Pparg overexpression in PDGFRβ+ mural cells give rise to healthier white adipocytes under high-fat diet-induced obesity. Furthermore, Zfp423+ PDGFRβ+ cells, which are the PCs that are committed to adipogenic lineage, contribute to approximately 10% of the white adipocytes in gonadal WAT following high-fat diet feeding. Moreover, these cells demonstrate the ability to differentiate into beige adipocytes in small clusters under prolonged cold exposure for two weeks; of note, this occurs in multiple waves depending on the extent and time course of cold stress [14]. A recent study focusing on BAT demonstrated that PDGFRβ+ PCs gave rise to brown adipocytes at an early stage, but not in adulthood [15].
NG2—It is found to be expressed on the surface of PCs during vasculogenic and angiogenic processes [52,53], as well as on some adipocytes. A lineage-tracing study demonstrated that NG2+ cells marked a portion of the mural cells and 100% of white adipocytes in subcutaneous and periscapular regions under room temperature, but only tracked mural cells in the visceral depot vasculatures without signals in adipocytes [23]. Interestingly, under cold exposure, approximately 50% of the UCP1+ beige cells originated from NG2+ PCs in subcutaneous and visceral perigonadal depots, suggesting the existence of other potential progenitor sources contributing to beige adipocytes [23]. However, NG2+ cells do not contribute to intramyocardial adipocytes in postnatal development or under adult homeostasis [47].
TBX18—It serves as a robust marker for identifying mural cells, including PCs and vascular smooth muscle cells [48]. Lineage-tracing mouse studies demonstrated that TBX18 neither traced to white adipocyte under either chow or high-fat diets, nor did it lead to a significant contribution to beige cells after 14 days of treatment with a β3-adrenergic receptor agonist [48]. Likewise, another study demonstrated that TBX18 plays a minor role in de novo beige adipogenesis [54]. However, in BAT, TBX18+ PCs act as progenitors of brown adipocytes in multiple regions, such as thoracic perivascular and supraclavicular depots, but not in intrascapular and periaortic regions, suggesting that TBX18+ PCs contribute to brown adipocytes in a depot-specific manner [15].
α-SMA—Similar to TBX18, α-SMA was not expressed in mature adipocytes, but was restricted to vasculatures in subcutaneous and visceral adipose tissue under normal conditions. However, upon cold exposure for 7 days, α-SMA+ PCs were fated into de novo beige adipogenesis and contributed to 55–68% of beige adipocytes in inguinal and perigonadal adipose depots [23].
NESTIN—It labels a subset of pericyte-like cells that possess somatic stem/progenitor cell properties [55]. Iwayama T. et al. [24] demonstrated that NESTIN was expressed in the PCs in WAT; and these NESTIN+ PCs have the potential to differentiate into either adipocytes or profibrotic cells. Especially, when PDGFRα+ was overexpressed in NESTIN+ PCs, these cells were fated into profibrotic cells by increasing the production of collagen [24], while the adipogenesis was inhibited.
CD146+—CD146+CD31CD45 PCs from adipose tissue prefer to differentiate into adipocytes, while the periosteal CD146+ PCs tend to be more mineralized in vitro and ossification in vivo [49]. These results suggest that CD146+ PCs hold a tissue-specific potential of differentiating into either adipogenic or osteogenic cells. A key regulator in this fate determination of CD146+ PCs is the T cell lymphoma invasion and metastasis 1 (TIAM1), which is highly expressed in adipose tissue but not in the skeleton. TIAM1 affects the morphology of adipose tissue-derived CD146+ PCs and increases the potential for adipogenic differentiation, while TIAM1 knockdown promotes osteogenic differentiation over adipogenesis [50].
As discussed earlier, none of the single molecular markers could uniquely identify PCs in general, or effectively distinguish them from other cell types, such as mural cells and fibroblasts. Future studies utilizing the single-cell RNA-seq technique will provide more informative data, shedding light on the heterogeneity of this cell population [26,56,57]. Furthermore, it remains unclear whether these PC progenitors would influence adipocyte dynamics under conditions such as physical exercise, diabetes, hypertension, fatty liver disease, and other metabolic complications [58,59].

4. Pericytes in the Bone Marrow Niche

Bone is also highly vascularized, with the blood vessels presenting throughout the bone tissue except in cartilaginous areas such as the growth plate [60,61,62,63]. The vasculature is a key component of the bone marrow microenvironment. Of note, PCs around vasculatures provide critical signals for bone marrow niche homeostasis, such as stromal cell proliferation, hematopoietic stem cell (HSC) maintenance, as well as the regulation of osteoblast, osteoclast, and adipocyte differentiation [64,65].
Two subtypes of vessels have been classified in the bone marrow based on their marker expression and functional characteristics, including type-H, which is localized in the proximal metaphyseal regions with higher blood flow, and type-L, which is mainly located in the diaphyseal regions and consists predominantly of sinusoidal-like vessels [66,67]. The distribution of PCs varies between these two distinct types of bone marrow vessels. For example, type-H capillaries are surrounded by perivascular cells expressing PDGFRβ and NG2 [68], whereas type-L blood vessels are surrounded by perivascular cells expressing leptin receptor (LepR) [69] and reticular cells abundant in CXCL12 (CAR) [70].
PDGF-PDGFRβ signaling in Osterix-expressing cells are critical for the recruitment, expansion, and angiotropism of skeletal stem and progenitor cells during bone repair, which are essential processes for effective fracture healing [71]. NG2+ PCs are critical for HSC localization to arterioles and the maintenance of their quiescent status [72]. LepR+ cells have the potential to differentiate into osteoblasts, chondrocytes, and adipocytes [73]. Notably, LepR labels 70% and 90% of bone marrow adipocytes at 2 and 6 months of age, respectively [73]. Although LepR+ cells barely contribute to bone formation when mice were younger than 2 months old, this proportion increases with age, reaching up to ~80% when mice were 14 months old [73]. Of note, leptin-lepR signaling in skeletal stem cells inhibits osteogenesis and promotes adipogenesis in response to a high-fat diet [74], and impairs bone regeneration after injury. CAR cells are scattered throughout the bone marrow, creating a network with the blood vessels [70,75]. These cells demonstrated the potential to differentiate into adipocytes both in vitro [76] and in vivo [77]. The pre-adipocyte-like CAR cells are also readily lipid-laden because CXCL12 deletion directly converted these cells into mature bone marrow adipocytes. Moreover, pre-adipocyte-like CAR cells communicate with hematopoietic cells through the CXCL12–CXCR4 pathway to regulate HSC retention, quiescence, and repopulation [77].
LepR+ cells and CAR cells overlap with each other to some extent [73,78], and both cell populations express high level of adipogenic markers, such as Pparg, Adipoq, and Cebpa [73,76]. Therefore, Zhong et al. described that LepR+/CAR cells could be marrow adipogenic lineage precursors (MALPs) [79], which were identified in the bone marrow niche through a single-cell RNA-sequencing approach [80]. MALPs express adipogenic markers (such as Pparg, Cebpa, Adipoq, Apoe, and Lpl), without lipid accumulation (Perilipin) [79]. Interestingly, MALPs also express PCs markers, including PDGFRβ and Laminin [80], and are exhibited as star-shaped PCs, with many dendritic processes extending and connecting around the endothelial wall [80].
Although bone marrow PCs express PDGFRβ, NG2, LepR, and/or CXCL12, these markers are not exclusive to PCs, as they are also expressed in stromal cells and/or MALPs. This complexity leads to questions about how to distinguish the typical PCs from bone marrow stromal cells and adipogenic MALPs, which require further studies. Overall, these findings suggest that PCs have a significant impact on adipogenesis in the bone marrow and influence stromal cells proliferation, HSC maintenance, and other mesenchymal cells.

5. Pericyte Functions in Adipose Tissue

As described above, the existence of PCs in adipose tissue has drawn more attention from researchers, prompting the functional studies of this cell population both locally and systematically. Overall, the primary functions of PCs in adipose tissue include maintaining vasculature integrity, facilitating angiogenesis, controlling blood flow, and serving as a stem/progenitor cell pool (Table 2).
Vasculature integrity—PCs intimately envelop endothelial cells in capillaries and microvessels [85], and are therefore predominantly found in the abluminal wall of blood vessels, where they contribute to the maintenance of capillary integrity and vascular permeability [81]. The basal membrane of the PC forms a continuous connection with the endothelial cells; both cell populations could secrete extracellular matrix proteins (mainly collagen IV and glycoprotein laminin) to maintain the structural integrity of blood vessels. The PCs could also emit protrusions that insert into the endothelial cell invaginations (cavities) and occasional interruptions of the basement membrane, providing essential support and structure for cell–cell communications [82,83]. Beyond their roles in regulating or stabilizing the function of blood vessels, PCs could be disrupted by pathological processes, and participate in vascular tissue remodeling [81,82,83,84].
It is noteworthy that the density of the endothelial cell/PC ratio varies across tissues, suggesting that PCs may perform specialized functions that differ between organs. The highest ratio of endothelial cells versus PCs is found in the central nervous system and retina [82,106,107], approximately 1:1, compared with other organs and tissues such as kidney (2.5:1), lung (7–9:1), skin, liver (10:1), cardiac microvasculature (2–3:1), and skeletal muscle (100:1) [108,109,110,111]. However, the proportion of PCs in adipose tissue remains undetermined.
Angiogenesis—PCs are the first cells to invade newly vascularized tissues, determining the location of sprout formation [86,87,88]. They actively participate in recruitment, extracellular matrix modulation, and paracrine signaling, and direct interactions with endothelial cells [112]. PC proliferation and migration is closely coordinated with the behavior of adjacent endothelial cells, demonstrating the essential collaboration between both cell types during angiogenesis. Indeed, the co-culture of human adipose tissue-derived CD146+ PCs with human umbilical vein endothelial cells (HUVECs) demonstrated a clear promoting effect on vessel sprouting during the angiogenesis [89]. Furthermore, the pro-angiogenic efficacy of adipose tissue-derived PCs on tube formation and cell migration was enhanced by Nel-like protein-1 (NELL-1), and promoted bone formation in an osteonecrosis mouse model [113]. Moreover, PCs have been found to ameliorate ischemia after being transplanted into a mouse model with severe hind limb ischemia [114,115], and improve the blood flow in mice during femoral artery ligation [116], suggesting their potential as promising targets for vascular regeneration. It is important to note, however, that their heterogeneity implies that different PC subpopulations may have distinct functions based on the tissue of origin and surface markers [117].
Capillary blood flow—The PCs have the abilities to induce vasoconstriction or vasodilation within the capillary beds in order to control the vascular diameter as well as the blood flow, akin to the smooth muscle cells of larger vessels. PCs also express cholinergic and adrenergic receptors (α-2 and β-2), where a β-adrenergic response leads to relaxation, while an α-2 response would be antagonistic and induce contraction. There are also other vasoactive substances that bind to PCs, such as angiotensin II and endothelin 1, and function as paracrine signals to regulate contraction and relaxation [90]. Moreover, using optogenetic approaches, the stimulation of the PCs causes excitation that leads to the contractions of blood vessels in brain [91], whereas Halorhodopsin channel hyperpolarization in PCs, which inhibits cell activities, results in increased capillary blood flow in the retina [92]. The modulation of PC activities provides opportunities to optimize the microvascular network within adipose tissue, thereby improving perfusion and nutrient exchange. This manipulation not only holds potential for mitigating hypoxia within adipose tissue, but also for fostering a more conducive environment for adipocyte function. Optimizing capillary blood flow through PCs may have implications for metabolic health, as it could affect adipose tissue expansion, adipokine secretion, and overall tissue homeostasis.
Stemness property—PCs possess the capacity for self-renewal and differentiation into other cell lineages, such as mature adipocytes, osteoblasts, and other mesenchymal cell types [25,93,94,95,96,97]. Therefore, they have been implicated as a potential reservoir of multipotent stem cells in adults [55,81,93,118,119]. In adipose tissue, PCs exist in the stromal vascular fraction (SVF) [11], which contains cells that are crucial for adipose tissue plasticity, angiogenesis, and neovascularization [120,121]. Notably, it has been demonstrated that PCs in close proximity to vasculature serve as an important source of adipogenic progenitor cells [98,99,100,101,122], which has been discussed in the “hallmarks” section above. In addition, Olson and Soriano found that PDGFRβ activation driven by Sox2-Cre in epiblasts, which include PCs and mesenchymal cells, inhibits white adipocyte differentiation [123]. In contrast, the deletion of PDGFRβ enhances white, brown, and beige adipogenesis [124]. Interestingly, the stemness property of PCs has been applied in reconstructive and tissue engineering therapies. For example, human adipose-tissue-derived stem cells (ASCs) isolated from lipoaspirate, expressing CD146, including PCs and adventitial components, have been demonstrated to have angiogenic and adipogeneic properties in vitro [102]. These cells have also been shown to have the capability to undergo osteogenic differentiation in vitro and form bone in vivo, suggesting their potential as a source for bone formation [103] and the possibility of contributing to bone healing [104]. In addition, a study using human ASC-derived PCs, injected into NOD-SCID mice, demonstrated the enhancement of retinal microvascular stabilization in mouse models of retinopathic vasculopathy [125].
Beige adipocytes have been gaining more attention from biologists, as these cells arise in WAT following thermogenic induction [126]. Interestingly, these beige adipocytes are located around the vasculature, sharing the same location with PCs (Figure 2). A groundbreaking study by Clack and Clack (1940) had revealed that de novo adipogenesis could occur in the close proximity of blood vessels, suggesting that adipogenic progenitors might be a type of blood vessel wall cells [48]. Indeed, perivascular cells (vascular smooth muscle cells and PCs) have been proven to give rise not only to white adipocytes, but also to differentiate into beige adipocytes [47,105,122]. Berry et al. [23] also evaluated a variety of mural cell markers, including SM22, Myh11, NG2, PDGFRα, and SMA, affirming that these cells indeed serve as an important source for beige adipocyte induction during cold exposure. However, further data analysis or future studies are required to better understand which of these markers truly represent PCs in WAT. Despite efforts to elucidate the ideal identity of the adipogenic progenitors among PCs, there are frequent contradictions in the findings, attributed not only to a variety of lineage tracing markers, but also to different experimental conditions [48].

6. Conclusions and Prospects

PCs have emerged as promising and multifaceted cells in various adipose tissues, orchestrating a series of functions crucial for adipose tissue homeostasis. Their regulatory roles in adipogenesis and angiogenesis highlight their importance in the formation of the adipose tissue microenvironment. The manipulation of PCs holds great potential to influence capillary integrity, angiogenesis, blood flow, and adipogenesis, thus impacting the metabolic health of adipose tissue. As we delve deeper into understanding the complexities of PC biology, we open new avenues for innovative therapeutic interventions in conditions related to adipose tissue dysfunction, offering hope for addressing issues such as obesity and metabolic disorders. Further research is required to fully understand the mechanisms, triggers, and functional consequences of PC-to-adipocyte differentiation. Continued investigations will shed more light on the role of PCs in adipose tissue biology and the progression of metabolic diseases related to adipose tissue.

Author Contributions

C.d.C.P. designed the structure of this paper and wrote this manuscript. Z.L. and A.B. supervised and checked the logical structure of the manuscript and the appropriateness of the figures. All authors have read and agreed to the published version of the manuscript.

Funding

This work was supported by doctoral fellowships from Fundação Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES) to CCP and NIH to ZL (1P20GM121301).

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

Not applicable.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Rouget, C. Memoire sur le develloppment, la structure et les propietes physiologiques des capillaries senguins et lymphatiques. Arch. Physiol. 1873, 5, 603–663. [Google Scholar]
  2. Zimmermann, K.W. Der feinere bau der blutcapillaren. Anat. Embryol. 1923, 68, 29–109. [Google Scholar]
  3. Hirschi, K.K.; D’Amore, P.A. Pericytes in the microvasculature. Cardiovasc. Res. 1996, 32, 687–698. [Google Scholar] [CrossRef] [PubMed]
  4. Díaz-Flores, L.; Gutiérrez, R.; Varela, H.; Rancel, N.; Valladares, F. Microvascular pericytes, a review of their morphological and functional characteristics. Histol. Histopathol. 1991, 6, 269–286. [Google Scholar] [PubMed]
  5. Zhang, J.; Du, C.; Guo, W.; Li, P.; Liu, S.; Yuan, Z.; Yang, J.; Sun, X.; Yin, H.; Guo, Q.; et al. Adipose Tissue-Derived Pericytes for Cartilage Tissue Engineering. Curr. Stem. Cell Res. Ther. 2017, 12, 513–521. [Google Scholar] [CrossRef] [PubMed]
  6. Lyle, L.T.; Lockman, P.R.; Adkins, C.E.; Mohammad, A.S.; Sechrest, E.; Hua, E.; Palmieri, D.; Liewehr, D.J.; Steinberg, S.M.; Kloc, W.; et al. Alterations in Pericyte Subpopulations Are Associated with Elevated Blood-Tumor Barrier Permeability in Experimental Brain Metastasis of Breast Cancer. Clin. Cancer Res. 2016, 22, 5287–5299. [Google Scholar] [CrossRef] [PubMed]
  7. Birbrair, A.; Borges, I.D.T.; Gilson Sena, I.F.; Almeida, G.G.; da Silva Meirelles, L.; Goncalves, R.; Mintz, A.; Delbono, O. How Plastic Are Pericytes? Stem Cells Dev. 2017, 26, 1013–1019. [Google Scholar] [CrossRef] [PubMed]
  8. Birbrair, A.; Zhang, T.; Files, D.C.; Mannava, S.; Smith, T.; Wang, Z.M.; Messi, M.L.; Mintz, A.; Delbono, O. Type-1 pericytes accumulate after tissue injury and produce collagen in an organ-dependent manner. Stem Cell Res. Ther. 2014, 5, 122. [Google Scholar] [CrossRef] [PubMed]
  9. Birbrair, A.; Zhang, T.; Wang, Z.M.; Messi, M.L.; Mintz, A.; Delbono, O. Type-1 pericytes participate in fibrous tissue deposition in aged skeletal muscle. Am. J. Physiol. Cell Physiol. 2013, 305, C1098–C1113. [Google Scholar] [CrossRef]
  10. Bergers, G.; Song, S. The role of pericytes in blood-vessel formation and maintenance. Neuro Oncol. 2005, 7, 452–464. [Google Scholar] [CrossRef]
  11. Park, K.W.; Halperin, D.S.; Tontonoz, P. Before they were fat: Adipocyte progenitors. Cell Metab. 2008, 8, 454–457. [Google Scholar] [CrossRef]
  12. Smyth, L.C.D.; Rustenhoven, J.; Scotter, E.L.; Schweder, P.; Faull, R.L.M.; Park, T.I.H.; Dragunow, M. Markers for human brain pericytes and smooth muscle cells. J. Chem. Neuroanat. 2018, 92, 48–60. [Google Scholar] [CrossRef] [PubMed]
  13. Onogi, Y.; Wada, T.; Kamiya, C.; Inata, K.; Matsuzawa, T.; Inaba, Y.; Kimura, K.; Inoue, H.; Yamamoto, S.; Ishii, Y.; et al. PDGFRbeta Regulates Adipose Tissue Expansion and Glucose Metabolism via Vascular Remodeling in Diet-Induced Obesity. Diabetes 2017, 66, 1008–1021. [Google Scholar] [CrossRef] [PubMed]
  14. Vishvanath, L.; MacPherson, K.A.; Hepler, C.; Wang, Q.A.; Shao, M.; Spurgin, S.B.; Wang, M.Y.; Kusminski, C.M.; Morley, T.S.; Gupta, R.K. Pdgfrbeta+ Mural Preadipocytes Contribute to Adipocyte Hyperplasia Induced by High-Fat-Diet Feeding and Prolonged Cold Exposure in Adult Mice. Cell Metab. 2016, 23, 350–359. [Google Scholar] [CrossRef] [PubMed]
  15. Shi, Z.; Xiong, S.; Hu, R.; Wang, Z.; Park, J.; Qian, Y.; Wang, J.; Bhalla, P.; Velupally, N.; Song, Q.; et al. The Notch-Pdgfrbeta axis suppresses brown adipocyte progenitor differentiation in early postnatal mice. bioRxiv 2023. [Google Scholar] [CrossRef]
  16. Vezzani, B.; Shaw, I.; Lesme, H.; Yong, L.; Khan, N.; Tremolada, C.; Peault, B. Higher Pericyte Content and Secretory Activity of Microfragmented Human Adipose Tissue Compared to Enzymatically Derived Stromal Vascular Fraction. Stem Cells Transl. Med. 2018, 7, 876–886. [Google Scholar] [CrossRef] [PubMed]
  17. Avolio, E.; Campagnolo, P.; Katare, R.; Madeddu, P. The role of cardiac pericytes in health and disease: Therapeutic targets for myocardial infarction. Nat. Rev. Cardiol. 2023, 21, 106–118. [Google Scholar] [CrossRef] [PubMed]
  18. Hsu, C.Y.; Salazar, M.G.; Miller, S.; Meyers, C.; Ding, C.; Hardy, W.; Peault, B.; James, A.W. Comparison of Human Tissue Microarray to Human Pericyte Transcriptome Yields Novel Perivascular Cell Markers. Stem Cells Dev. 2019, 28, 1214–1223. [Google Scholar] [CrossRef]
  19. Zimmerlin, L.; Donnenberg, V.S.; Rubin, J.P.; Donnenberg, A.D. Mesenchymal markers on human adipose stem/progenitor cells. Cytometry A 2013, 83, 134–140. [Google Scholar] [CrossRef]
  20. Zimmerlin, L.; Donnenberg, V.S.; Donnenberg, A.D. Pericytes: A universal adult tissue stem cell? Cytometry A 2012, 81, 12–14. [Google Scholar] [CrossRef]
  21. James, A.W.; Hindle, P.; Murray, I.R.; West, C.C.; Tawonsawatruk, T.; Shen, J.; Asatrian, G.; Zhang, X.; Nguyen, V.; Simpson, A.H.; et al. Pericytes for the treatment of orthopedic conditions. Pharmacol. Ther. 2017, 171, 93–103. [Google Scholar] [CrossRef] [PubMed]
  22. Murray, I.R.; Baily, J.E.; Chen, W.C.W.; Dar, A.; Gonzalez, Z.N.; Jensen, A.R.; Petrigliano, F.A.; Deb, A.; Henderson, N.C. Skeletal and cardiac muscle pericytes: Functions and therapeutic potential. Pharmacol. Ther. 2017, 171, 65–74. [Google Scholar] [CrossRef] [PubMed]
  23. Berry, D.C.; Jiang, Y.; Graff, J.M. Mouse strains to study cold-inducible beige progenitors and beige adipocyte formation and function. Nat. Commun. 2016, 7, 10184. [Google Scholar] [CrossRef]
  24. Iwayama, T.; Steele, C.; Yao, L.; Dozmorov, M.G.; Karamichos, D.; Wren, J.D.; Olson, L.E. PDGFRalpha signaling drives adipose tissue fibrosis by targeting progenitor cell plasticity. Genes Dev. 2015, 29, 1106–1119. [Google Scholar] [CrossRef] [PubMed]
  25. Mendez-Ferrer, S.; Michurina, T.V.; Ferraro, F.; Mazloom, A.R.; Macarthur, B.D.; Lira, S.A.; Scadden, D.T.; Ma’ayan, A.; Enikolopov, G.N.; Frenette, P.S. Mesenchymal and haematopoietic stem cells form a unique bone marrow niche. Nature 2010, 466, 829–834. [Google Scholar] [CrossRef] [PubMed]
  26. Baek, S.H.; Maiorino, E.; Kim, H.; Glass, K.; Raby, B.A.; Yuan, K. Single Cell Transcriptomic Analysis Reveals Organ Specific Pericyte Markers and Identities. Front. Cardiovasc. Med. 2022, 9, 876591. [Google Scholar] [CrossRef] [PubMed]
  27. Crouch, E.E.; Liu, C.; Silva-Vargas, V.; Doetsch, F. Regional and stage-specific effects of prospectively purified vascular cells on the adult V-SVZ neural stem cell lineage. J. Neurosci. 2015, 35, 4528–4539. [Google Scholar] [CrossRef]
  28. Ahmed, T.A.; Shousha, W.G.; Abdo, S.M.; Mohamed, I.K.; El-Badri, N. Human Adipose-Derived Pericytes: Biological Characterization and Reprogramming into Induced Pluripotent Stem Cells. Cell Physiol. Biochem. 2020, 54, 271–286. [Google Scholar] [CrossRef]
  29. Bandopadhyay, R.; Orte, C.; Lawrenson, J.G.; Reid, A.R.; De Silva, S.; Allt, G. Contractile proteins in pericytes at the blood-brain and blood-retinal barriers. J. Neurocytol. 2001, 30, 35–44. [Google Scholar] [CrossRef]
  30. Stapor, P.C.; Sweat, R.S.; Dashti, D.C.; Betancourt, A.M.; Murfee, W.L. Pericyte dynamics during angiogenesis: New insights from new identities. J. Vasc. Res. 2014, 51, 163–174. [Google Scholar] [CrossRef]
  31. Ivanova, E.; Kovacs-Oller, T.; Sagdullaev, B.T. Vascular Pericyte Impairment and Connexin43 Gap Junction Deficit Contribute to Vasomotor Decline in Diabetic Retinopathy. J. Neurosci. 2017, 37, 7580–7594. [Google Scholar] [CrossRef] [PubMed]
  32. Bagley, R.G.; Honma, N.; Weber, W.; Boutin, P.; Rouleau, C.; Shankara, S.; Kataoka, S.; Ishida, I.; Roberts, B.L.; Teicher, B.A. Endosialin/TEM 1/CD248 is a pericyte marker of embryonic and tumor neovascularization. Microvasc. Res. 2008, 76, 180–188. [Google Scholar] [CrossRef] [PubMed]
  33. Simonavicius, N.; Robertson, D.; Bax, D.A.; Jones, C.; Huijbers, I.J.; Isacke, C.M. Endosialin (CD248) is a marker of tumor-associated pericytes in high-grade glioma. Mod. Pathol. 2008, 21, 308–315. [Google Scholar] [CrossRef] [PubMed]
  34. Risau, W.; Dingler, A.; Albrecht, U.; Dehouck, M.P.; Cecchelli, R. Blood-brain barrier pericytes are the main source of γ-glutamyltranspeptidase activity in brain capillaries. J. Neurochem. 1992, 58, 667–672. [Google Scholar] [CrossRef] [PubMed]
  35. Routray, C.; Liu, C.; Yaqoob, U.; Billadeau, D.D.; Bloch, K.D.; Kaibuchi, K.; Shah, V.H.; Kang, N. Protein kinase G signaling disrupts Rac1-dependent focal adhesion assembly in liver specific pericytes. Am. J. Physiol. Cell Physiol. 2011, 301, C66–C74. [Google Scholar] [CrossRef] [PubMed]
  36. Alliot, F.; Rutin, J.; Leenen, P.J.; Pessac, B. Pericytes and periendothelial cells of brain parenchyma vessels co-express aminopeptidase N, aminopeptidase A, and nestin. J. Neurosci. Res. 1999, 58, 367–378. [Google Scholar] [CrossRef]
  37. Berger, M.; Bergers, G.; Arnold, B.; Hammerling, G.J.; Ganss, R. Regulator of G-protein signaling-5 induction in pericytes coincides with active vessel remodeling during neovascularization. Blood 2005, 105, 1094–1101. [Google Scholar] [CrossRef] [PubMed]
  38. Roth, M.; Gaceb, A.; Enstrom, A.; Padel, T.; Genove, G.; Ozen, I.; Paul, G. Regulator of G-protein signaling 5 regulates the shift from perivascular to parenchymal pericytes in the chronic phase after stroke. FASEB J. 2019, 33, 8990–8998. [Google Scholar] [CrossRef]
  39. Hosford, P.S.; Christie, I.N.; Niranjan, A.; Aziz, Q.; Anderson, N.; Ang, R.; Lythgoe, M.F.; Wells, J.A.; Tinker, A.; Gourine, A.V. A critical role for the ATP-sensitive potassium channel subunit K(IR)6.1 in the control of cerebral blood flow. J. Cereb. Blood Flow. Metab. 2019, 39, 2089–2095. [Google Scholar] [CrossRef]
  40. Sancho, M.; Klug, N.R.; Mughal, A.; Koide, M.; Huerta de la Cruz, S.; Heppner, T.J.; Bonev, A.D.; Hill-Eubanks, D.; Nelson, M.T. Adenosine signaling activates ATP-sensitive K(+) channels in endothelial cells and pericytes in CNS capillaries. Sci. Signal 2022, 15, eabl5405. [Google Scholar] [CrossRef]
  41. Bondjers, C.; He, L.; Takemoto, M.; Norlin, J.; Asker, N.; Hellstrom, M.; Lindahl, P.; Betsholtz, C. Microarray analysis of blood microvessels from PDGF-B and PDGF-Rbeta mutant mice identifies novel markers for brain pericytes. FASEB J. 2006, 20, 1703–1705. [Google Scholar] [CrossRef] [PubMed]
  42. Chi Sabins, N.; Taylor, J.L.; Fabian, K.P.; Appleman, L.J.; Maranchie, J.K.; Stolz, D.B.; Storkus, W.J. DLK1: A novel target for immunotherapeutic remodeling of the tumor blood vasculature. Mol. Ther. 2013, 21, 1958–1968. [Google Scholar] [CrossRef] [PubMed]
  43. Zhu, N.L.; Asahina, K.; Wang, J.; Ueno, A.; Lazaro, R.; Miyaoka, Y.; Miyajima, A.; Tsukamoto, H. Hepatic stellate cell-derived delta-like homolog 1 (DLK1) protein in liver regeneration. J. Biol. Chem. 2012, 287, 10355–10367. [Google Scholar] [CrossRef] [PubMed]
  44. van Dijk, C.G.; Nieuweboer, F.E.; Pei, J.Y.; Xu, Y.J.; Burgisser, P.; van Mulligen, E.; el Azzouzi, H.; Duncker, D.J.; Verhaar, M.C.; Cheng, C. The complex mural cell: Pericyte function in health and disease. Int. J. Cardiol. 2015, 190, 75–89. [Google Scholar] [CrossRef] [PubMed]
  45. Sacchetti, B.; Funari, A.; Remoli, C.; Giannicola, G.; Kogler, G.; Liedtke, S.; Cossu, G.; Serafini, M.; Sampaolesi, M.; Tagliafico, E.; et al. No Identical “Mesenchymal Stem Cells” at Different Times and Sites: Human Committed Progenitors of Distinct Origin and Differentiation Potential Are Incorporated as Adventitial Cells in Microvessels. Stem Cell Rep. 2016, 6, 897–913. [Google Scholar] [CrossRef] [PubMed]
  46. Kumar, A.; D’Souza, S.S.; Moskvin, O.V.; Toh, H.; Wang, B.; Zhang, J.; Swanson, S.; Guo, L.W.; Thomson, J.A.; Slukvin, I.I. Specification and Diversification of Pericytes and Smooth Muscle Cells from Mesenchymoangioblasts. Cell Rep. 2017, 19, 1902–1916. [Google Scholar] [CrossRef] [PubMed]
  47. Jiang, Y.; Berry, D.C.; Tang, W.; Graff, J.M. Independent stem cell lineages regulate adipose organogenesis and adipose homeostasis. Cell Rep. 2014, 9, 1007–1022. [Google Scholar] [CrossRef] [PubMed]
  48. Cattaneo, P.; Mukherjee, D.; Spinozzi, S.; Zhang, L.; Larcher, V.; Stallcup, W.B.; Kataoka, H.; Chen, J.; Dimmeler, S.; Evans, S.M.; et al. Parallel Lineage-Tracing Studies Establish Fibroblasts as the Prevailing In Vivo Adipocyte Progenitor. Cell Rep. 2020, 30, 571–582. [Google Scholar] [CrossRef]
  49. Xu, J.; Li, D.; Hsu, C.Y.; Tian, Y.; Zhang, L.; Wang, Y.; Tower, R.J.; Chang, L.; Meyers, C.A.; Gao, Y.; et al. Comparison of skeletal and soft tissue pericytes identifies CXCR4(+) bone forming mural cells in human tissues. Bone Res. 2020, 8, 22. [Google Scholar] [CrossRef]
  50. Hsu, G.C.; Wang, Y.; Lu, A.Z.; Gomez-Salazar, M.A.; Xu, J.; Li, D.; Meyers, C.; Negri, S.; Wangsiricharoen, S.; Broderick, K.; et al. TIAM1 acts as an actin organization regulator to control adipose tissue-derived pericyte cell fate. JCI Insight 2023, 8, e159141. [Google Scholar] [CrossRef]
  51. Shao, M.; Vishvanath, L.; Busbuso, N.C.; Hepler, C.; Shan, B.; Sharma, A.X.; Chen, S.; Yu, X.; An, Y.A.; Zhu, Y.; et al. De novo adipocyte differentiation from Pdgfrbeta(+) preadipocytes protects against pathologic visceral adipose expansion in obesity. Nat. Commun. 2018, 9, 890. [Google Scholar] [CrossRef] [PubMed]
  52. Minocha, S.; Valloton, D.; Brunet, I.; Eichmann, A.; Hornung, J.P.; Lebrand, C. NG2 glia are required for vessel network formation during embryonic development. eLife 2015, 4, e09102. [Google Scholar] [CrossRef]
  53. Ozerdem, U.; Grako, K.A.; Dahlin-Huppe, K.; Monosov, E.; Stallcup, W.B. NG2 proteoglycan is expressed exclusively by mural cells during vascular morphogenesis. Dev. Dyn. 2001, 222, 218–227. [Google Scholar] [CrossRef] [PubMed]
  54. Guimaraes-Camboa, N.; Cattaneo, P.; Sun, Y.; Moore-Morris, T.; Gu, Y.; Dalton, N.D.; Rockenstein, E.; Masliah, E.; Peterson, K.L.; Stallcup, W.B.; et al. Pericytes of Multiple Organs Do Not Behave as Mesenchymal Stem Cells In Vivo. Cell Stem Cell 2017, 20, 345–359.e5. [Google Scholar] [CrossRef] [PubMed]
  55. Dore-Duffy, P.; Cleary, K. Morphology and properties of pericytes. Methods Mol. Biol. 2011, 686, 49–68. [Google Scholar] [CrossRef]
  56. van Splunder, H.; Villacampa, P.; Martinez-Romero, A.; Graupera, M. Pericytes in the disease spotlight. Trends Cell Biol. 2023, 34, 58–71. [Google Scholar] [CrossRef]
  57. Muhl, L.; Mocci, G.; Pietila, R.; Liu, J.; He, L.; Genove, G.; Leptidis, S.; Gustafsson, S.; Buyandelger, B.; Raschperger, E.; et al. A single-cell transcriptomic inventory of murine smooth muscle cells. Dev. Cell 2022, 57, 2426–2443. [Google Scholar] [CrossRef]
  58. DeBari, M.K.; Abbott, R.D. Adipose Tissue Fibrosis: Mechanisms, Models, and Importance. Int. J. Mol. Sci. 2020, 21, 6030. [Google Scholar] [CrossRef]
  59. Datta, R.; Podolsky, M.J.; Atabai, K. Fat fibrosis: Friend or foe? JCI Insight 2018, 3, e122289. [Google Scholar] [CrossRef]
  60. Filipowska, J.; Tomaszewski, K.A.; Niedzwiedzki, L.; Walocha, J.A.; Niedzwiedzki, T. The role of vasculature in bone development, regeneration and proper systemic functioning. Angiogenesis 2017, 20, 291–302. [Google Scholar] [CrossRef]
  61. Lafage-Proust, M.H.; Roche, B.; Langer, M.; Cleret, D.; Vanden Bossche, A.; Olivier, T.; Vico, L. Assessment of bone vascularization and its role in bone remodeling. Bonekey Rep. 2015, 4, 662. [Google Scholar] [CrossRef] [PubMed]
  62. Sivaraj, K.K.; Adams, R.H. Blood vessel formation and function in bone. Development 2016, 143, 2706–2715. [Google Scholar] [CrossRef] [PubMed]
  63. Yu, W.; Zhong, L.; Yao, L.; Wei, Y.; Gui, T.; Li, Z.; Kim, H.; Holdreith, N.; Jiang, X.; Tong, W.; et al. Bone marrow adipogenic lineage precursors promote osteoclastogenesis in bone remodeling and pathologic bone loss. J. Clin. Investig. 2021, 131, e140214. [Google Scholar] [CrossRef] [PubMed]
  64. Biswas, L.; Chen, J.; De Angelis, J.; Singh, A.; Owen-Woods, C.; Ding, Z.; Pujol, J.M.; Kumar, N.; Zeng, F.; Ramasamy, S.K.; et al. Lymphatic vessels in bone support regeneration after injury. Cell 2023, 186, 382–397. [Google Scholar] [CrossRef] [PubMed]
  65. Chen, J.; Hendriks, M.; Chatzis, A.; Ramasamy, S.K.; Kusumbe, A.P. Bone Vasculature and Bone Marrow Vascular Niches in Health and Disease. J. Bone Miner. Res. 2020, 35, 2103–2120. [Google Scholar] [CrossRef] [PubMed]
  66. Owen-Woods, C.; Kusumbe, A. Fundamentals of bone vasculature: Specialization, interactions and functions. Semin Cell Dev. Biol. 2022, 123, 36–47. [Google Scholar] [CrossRef]
  67. Kusumbe, A.P.; Ramasamy, S.K.; Adams, R.H. Coupling of angiogenesis and osteogenesis by a specific vessel subtype in bone. Nature 2014, 507, 323–328. [Google Scholar] [CrossRef]
  68. Kusumbe, A.P.; Ramasamy, S.K.; Itkin, T.; Mae, M.A.; Langen, U.H.; Betsholtz, C.; Lapidot, T.; Adams, R.H. Age-dependent modulation of vascular niches for haematopoietic stem cells. Nature 2016, 532, 380–384. [Google Scholar] [CrossRef]
  69. Ding, L.; Saunders, T.L.; Enikolopov, G.; Morrison, S.J. Endothelial and perivascular cells maintain haematopoietic stem cells. Nature 2012, 481, 457–462. [Google Scholar] [CrossRef]
  70. Sugiyama, T.; Kohara, H.; Noda, M.; Nagasawa, T. Maintenance of the hematopoietic stem cell pool by CXCL12-CXCR4 chemokine signaling in bone marrow stromal cell niches. Immunity 2006, 25, 977–988. [Google Scholar] [CrossRef]
  71. Bohm, A.M.; Dirckx, N.; Tower, R.J.; Peredo, N.; Vanuytven, S.; Theunis, K.; Nefyodova, E.; Cardoen, R.; Lindner, V.; Voet, T.; et al. Activation of Skeletal Stem and Progenitor Cells for Bone Regeneration Is Driven by PDGFRbeta Signaling. Dev. Cell 2019, 51, 236–254.e212. [Google Scholar] [CrossRef] [PubMed]
  72. Kunisaki, Y.; Bruns, I.; Scheiermann, C.; Ahmed, J.; Pinho, S.; Zhang, D.; Mizoguchi, T.; Wei, Q.; Lucas, D.; Ito, K.; et al. Arteriolar niches maintain haematopoietic stem cell quiescence. Nature 2013, 502, 637–643. [Google Scholar] [CrossRef] [PubMed]
  73. Zhou, B.O.; Yue, R.; Murphy, M.M.; Peyer, J.G.; Morrison, S.J. Leptin-receptor-expressing mesenchymal stromal cells represent the main source of bone formed by adult bone marrow. Cell Stem Cell 2014, 15, 154–168. [Google Scholar] [CrossRef]
  74. Yue, R.; Zhou, B.O.; Shimada, I.S.; Zhao, Z.; Morrison, S.J. Leptin Receptor Promotes Adipogenesis and Reduces Osteogenesis by Regulating Mesenchymal Stromal Cells in Adult Bone Marrow. Cell Stem Cell 2016, 18, 782–796. [Google Scholar] [CrossRef] [PubMed]
  75. Tokoyoda, K.; Egawa, T.; Sugiyama, T.; Choi, B.I.; Nagasawa, T. Cellular niches controlling B lymphocyte behavior within bone marrow during development. Immunity 2004, 20, 707–718. [Google Scholar] [CrossRef]
  76. Omatsu, Y.; Sugiyama, T.; Kohara, H.; Kondoh, G.; Fujii, N.; Kohno, K.; Nagasawa, T. The essential functions of adipo-osteogenic progenitors as the hematopoietic stem and progenitor cell niche. Immunity 2010, 33, 387–399. [Google Scholar] [CrossRef]
  77. Matsushita, Y.; Chu, A.K.Y.; Ono, W.; Welch, J.D.; Ono, N. Intercellular Interactions of an Adipogenic CXCL12-Expressing Stromal Cell Subset in Murine Bone Marrow. J. Bone Miner. Res. 2021, 36, 1145–1158. [Google Scholar] [CrossRef] [PubMed]
  78. Kara, N.; Xue, Y.; Zhao, Z.; Murphy, M.M.; Comazzetto, S.; Lesser, A.; Du, L.; Morrison, S.J. Endothelial and Leptin Receptor(+) cells promote the maintenance of stem cells and hematopoiesis in early postnatal murine bone marrow. Dev. Cell 2023, 58, 348–360. [Google Scholar] [CrossRef]
  79. Zhong, L.; Yao, L.; Seale, P.; Qin, L. Marrow adipogenic lineage precursor: A new cellular component of marrow adipose tissue. Best Pract. Res. Clin. Endocrinol. Metab. 2021, 35, 101518. [Google Scholar] [CrossRef]
  80. Zhong, L.; Yao, L.; Tower, R.J.; Wei, Y.; Miao, Z.; Park, J.; Shrestha, R.; Wang, L.; Yu, W.; Holdreith, N.; et al. Single cell transcriptomics identifies a unique adipose lineage cell population that regulates bone marrow environment. eLife 2020, 9, e54695. [Google Scholar] [CrossRef]
  81. Nwadozi, E.; Rudnicki, M.; Haas, T.L. Metabolic Coordination of Pericyte Phenotypes: Therapeutic Implications. Front. Cell Dev. Biol. 2020, 8, 77. [Google Scholar] [CrossRef] [PubMed]
  82. Armulik, A.; Genove, G.; Betsholtz, C. Pericytes: Developmental, physiological, and pathological perspectives, problems, and promises. Dev. Cell 2011, 21, 193–215. [Google Scholar] [CrossRef]
  83. Holm, A.; Heumann, T.; Augustin, H.G. Microvascular Mural Cell Organotypic Heterogeneity and Functional Plasticity. Trends Cell Biol. 2018, 28, 302–316. [Google Scholar] [CrossRef] [PubMed]
  84. Birbrair, A.; Zhang, T.; Wang, Z.M.; Messi, M.L.; Mintz, A.; Delbono, O. Pericytes at the intersection between tissue regeneration and pathology. Clin. Sci. 2015, 128, 81–93. [Google Scholar] [CrossRef]
  85. Andreeva, E.R.; Pugach, I.M.; Gordon, D.; Orekhov, A.N. Continuous subendothelial network formed by pericyte-like cells in human vascular bed. Tissue Cell 1998, 30, 127–135. [Google Scholar] [CrossRef] [PubMed]
  86. Nehls, V.; Denzer, K.; Drenckhahn, D. Pericyte involvement in capillary sprouting during angiogenesis in situ. Cell Tissue Res. 1992, 270, 469–474. [Google Scholar] [CrossRef] [PubMed]
  87. Ponce, A.M.; Price, R.J. Angiogenic stimulus determines the positioning of pericytes within capillary sprouts in vivo. Microvasc. Res. 2003, 65, 45–48. [Google Scholar] [CrossRef]
  88. Eilken, H.M.; Dieguez-Hurtado, R.; Schmidt, I.; Nakayama, M.; Jeong, H.W.; Arf, H.; Adams, S.; Ferrara, N.; Adams, R.H. Pericytes regulate VEGF-induced endothelial sprouting through VEGFR1. Nat. Commun. 2017, 8, 1574. [Google Scholar] [CrossRef]
  89. Gonzalez-Rubio, J.; Königs-Werner, H.; Cornelissen, C.G.; Thiebes, A.L. Differential behavior of pericytes and adipose stromal cells in vasculogenesis and angiogenesis. bioRxiv 2023. [Google Scholar] [CrossRef]
  90. Rucker, H.K.; Wynder, H.J.; Thomas, W.E. Cellular mechanisms of CNS pericytes. Brain Res. Bull. 2000, 51, 363–369. [Google Scholar] [CrossRef]
  91. Nelson, A.R.; Sagare, M.A.; Wang, Y.; Kisler, K.; Zhao, Z.; Zlokovic, B.V. Channelrhodopsin Excitation Contracts Brain Pericytes and Reduces Blood Flow in the Aging Mouse Brain in vivo. Front. Aging Neurosci. 2020, 12, 108. [Google Scholar] [CrossRef] [PubMed]
  92. Ivanova, E.; Corona, C.; Eleftheriou, C.G.; Bianchimano, P.; Sagdullaev, B.T. Retina-specific targeting of pericytes reveals structural diversity and enables control of capillary blood flow. J. Comp. Neurol. 2021, 529, 1121–1134. [Google Scholar] [CrossRef] [PubMed]
  93. Crisan, M.; Yap, S.; Casteilla, L.; Chen, C.W.; Corselli, M.; Park, T.S.; Andriolo, G.; Sun, B.; Zheng, B.; Zhang, L.; et al. A perivascular origin for mesenchymal stem cells in multiple human organs. Cell Stem Cell 2008, 3, 301–313. [Google Scholar] [CrossRef] [PubMed]
  94. Hoshino, A.; Chiba, H.; Nagai, K.; Ishii, G.; Ochiai, A. Human vascular adventitial fibroblasts contain mesenchymal stem/progenitor cells. Biochem. Biophys. Res. Commun. 2008, 368, 305–310. [Google Scholar] [CrossRef] [PubMed]
  95. Passman, J.N.; Dong, X.R.; Wu, S.P.; Maguire, C.T.; Hogan, K.A.; Bautch, V.L.; Majesky, M.W. A sonic hedgehog signaling domain in the arterial adventitia supports resident Sca1+ smooth muscle progenitor cells. Proc. Natl. Acad. Sci. USA 2008, 105, 9349–9354. [Google Scholar] [CrossRef] [PubMed]
  96. Corselli, M.; Chen, C.W.; Sun, B.; Yap, S.; Rubin, J.P.; Peault, B. The tunica adventitia of human arteries and veins as a source of mesenchymal stem cells. Stem Cells Dev. 2012, 21, 1299–1308. [Google Scholar] [CrossRef] [PubMed]
  97. Pierantozzi, E.; Badin, M.; Vezzani, B.; Curina, C.; Randazzo, D.; Petraglia, F.; Rossi, D.; Sorrentino, V. Human pericytes isolated from adipose tissue have better differentiation abilities than their mesenchymal stem cell counterparts. Cell Tissue Res. 2015, 361, 769–778. [Google Scholar] [CrossRef]
  98. Rodeheffer, M.S.; Birsoy, K.; Friedman, J.M. Identification of white adipocyte progenitor cells in vivo. Cell 2008, 135, 240–249. [Google Scholar] [CrossRef]
  99. Farrington-Rock, C.; Crofts, N.J.; Doherty, M.J.; Ashton, B.A.; Griffin-Jones, C.; Canfield, A.E. Chondrogenic and adipogenic potential of microvascular pericytes. Circulation 2004, 110, 2226–2232. [Google Scholar] [CrossRef]
  100. Lin, G.; Garcia, M.; Ning, H.; Banie, L.; Guo, Y.L.; Lue, T.F.; Lin, C.S. Defining stem and progenitor cells within adipose tissue. Stem Cells Dev. 2008, 17, 1053–1063. [Google Scholar] [CrossRef]
  101. Cai, X.; Lin, Y.; Hauschka, P.V.; Grottkau, B.E. Adipose stem cells originate from perivascular cells. Biol. Cell 2011, 103, 435–447. [Google Scholar] [CrossRef]
  102. Lauvrud, A.T.; Kelk, P.; Wiberg, M.; Kingham, P.J. Characterization of human adipose tissue-derived stem cells with enhanced angiogenic and adipogenic properties. J. Tissue Eng. Regen. Med. 2017, 11, 2490–2502. [Google Scholar] [CrossRef] [PubMed]
  103. James, A.W.; Zara, J.N.; Zhang, X.; Askarinam, A.; Goyal, R.; Chiang, M.; Yuan, W.; Chang, L.; Corselli, M.; Shen, J.; et al. Perivascular stem cells: A prospectively purified mesenchymal stem cell population for bone tissue engineering. Stem Cells Transl. Med. 2012, 1, 510–519. [Google Scholar] [CrossRef] [PubMed]
  104. Wang, Y.; Xu, J.; Chang, L.; Meyers, C.A.; Zhang, L.; Broderick, K.; Lee, M.; Peault, B.; James, A.W. Relative contributions of adipose-resident CD146(+) pericytes and CD34(+) adventitial progenitor cells in bone tissue engineering. NPJ Regen. Med. 2019, 4, 1. [Google Scholar] [CrossRef] [PubMed]
  105. Shao, M.; Wang, Q.A.; Song, A.; Vishvanath, L.; Busbuso, N.C.; Scherer, P.E.; Gupta, R.K. Cellular Origins of Beige Fat Cells Revisited. Diabetes 2019, 68, 1874–1885. [Google Scholar] [CrossRef] [PubMed]
  106. Bell, R.D.; Winkler, E.A.; Sagare, A.P.; Singh, I.; LaRue, B.; Deane, R.; Zlokovic, B.V. Pericytes control key neurovascular functions and neuronal phenotype in the adult brain and during brain aging. Neuron 2010, 68, 409–427. [Google Scholar] [CrossRef] [PubMed]
  107. Mathiisen, T.M.; Lehre, K.P.; Danbolt, N.C.; Ottersen, O.P. The perivascular astroglial sheath provides a complete covering of the brain microvessels: An electron microscopic 3D reconstruction. Glia 2010, 58, 1094–1103. [Google Scholar] [CrossRef]
  108. Hellerbrand, C. Hepatic stellate cells--the pericytes in the liver. Pflugers Arch. 2013, 465, 775–778. [Google Scholar] [CrossRef]
  109. Diaz-Flores, L.; Gutierrez, R.; Madrid, J.F.; Varela, H.; Valladares, F.; Acosta, E.; Martin-Vasallo, P.; Diaz-Flores, L., Jr. Pericytes. Morphofunction, interactions and pathology in a quiescent and activated mesenchymal cell niche. Histol. Histopathol. 2009, 24, 909–969. [Google Scholar] [CrossRef]
  110. Rudziak, P.; Ellis, C.G.; Kowalewska, P.M. Role and Molecular Mechanisms of Pericytes in Regulation of Leukocyte Diapedesis in Inflamed Tissues. Mediat. Inflamm. 2019, 2019, 4123605. [Google Scholar] [CrossRef]
  111. Nees, S.; Weiss, D.R.; Senftl, A.; Knott, M.; Forch, S.; Schnurr, M.; Weyrich, P.; Juchem, G. Isolation, bulk cultivation, and characterization of coronary microvascular pericytes: The second most frequent myocardial cell type in vitro. Am. J. Physiol. Heart Circ. Physiol. 2012, 302, H69–H84. [Google Scholar] [CrossRef] [PubMed]
  112. Gerhardt, H.; Betsholtz, C. Endothelial-pericyte interactions in angiogenesis. Cell Tissue Res. 2003, 314, 15–23. [Google Scholar] [CrossRef] [PubMed]
  113. An, H.J.; Ko, K.R.; Baek, M.; Jeong, Y.; Lee, H.H.; Kim, H.; Kim, D.K.; Lee, S.Y.; Lee, S. Pro-Angiogenic and Osteogenic Effects of Adipose Tissue-Derived Pericytes Synergistically Enhanced by Nel-like Protein-1. Cells 2021, 10, 2244. [Google Scholar] [CrossRef] [PubMed]
  114. Dar, A.; Domev, H.; Ben-Yosef, O.; Tzukerman, M.; Zeevi-Levin, N.; Novak, A.; Germanguz, I.; Amit, M.; Itskovitz-Eldor, J. Multipotent vasculogenic pericytes from human pluripotent stem cells promote recovery of murine ischemic limb. Circulation 2012, 125, 87–99. [Google Scholar] [CrossRef] [PubMed]
  115. Cathery, W.; Faulkner, A.; Maselli, D.; Madeddu, P. Concise Review: The Regenerative Journey of Pericytes Toward Clinical Translation. Stem Cells 2018, 36, 1295–1310. [Google Scholar] [CrossRef] [PubMed]
  116. Birbrair, A.; Zhang, T.; Wang, Z.M.; Messi, M.L.; Olson, J.D.; Mintz, A.; Delbono, O. Type-2 pericytes participate in normal and tumoral angiogenesis. Am. J. Physiol. Cell Physiol. 2014, 307, C25–C38. [Google Scholar] [CrossRef] [PubMed]
  117. Bodnar, R.J.; Satish, L.; Yates, C.C.; Wells, A. Pericytes: A newly recognized player in wound healing. Wound Repair. Regen. 2016, 24, 204–214. [Google Scholar] [CrossRef] [PubMed]
  118. Birbrair, A. Stem Cells Heterogeneity. Adv. Exp. Med. Biol. 2019, 1123, 1–3. [Google Scholar] [CrossRef]
  119. Collett, G.D.; Canfield, A.E. Angiogenesis and pericytes in the initiation of ectopic calcification. Circ. Res. 2005, 96, 930–938. [Google Scholar] [CrossRef]
  120. Bora, P.; Majumdar, A.S. Adipose tissue-derived stromal vascular fraction in regenerative medicine: A brief review on biology and translation. Stem Cell Res. Ther. 2017, 8, 145. [Google Scholar] [CrossRef]
  121. Klar, A.S.; Guven, S.; Zimoch, J.; Zapiorkowska, N.A.; Biedermann, T.; Bottcher-Haberzeth, S.; Meuli-Simmen, C.; Martin, I.; Scherberich, A.; Reichmann, E.; et al. Characterization of vasculogenic potential of human adipose-derived endothelial cells in a three-dimensional vascularized skin substitute. Pediatr. Surg. Int. 2016, 32, 17–27. [Google Scholar] [CrossRef]
  122. Tang, W.; Zeve, D.; Suh, J.M.; Bosnakovski, D.; Kyba, M.; Hammer, R.E.; Tallquist, M.D.; Graff, J.M. White fat progenitor cells reside in the adipose vasculature. Science 2008, 322, 583–586. [Google Scholar] [CrossRef]
  123. Olson, L.E.; Soriano, P. PDGFRbeta signaling regulates mural cell plasticity and inhibits fat development. Dev. Cell 2011, 20, 815–826. [Google Scholar] [CrossRef]
  124. Sun, C.; Sakashita, H.; Kim, J.; Tang, Z.; Upchurch, G.M.; Yao, L.; Berry, W.L.; Griffin, T.M.; Olson, L.E. Mosaic Mutant Analysis Identifies PDGFRalpha/PDGFRbeta as Negative Regulators of Adipogenesis. Cell Stem Cell 2020, 26, 707–721. [Google Scholar] [CrossRef]
  125. Mendel, T.A.; Clabough, E.B.; Kao, D.S.; Demidova-Rice, T.N.; Durham, J.T.; Zotter, B.C.; Seaman, S.A.; Cronk, S.M.; Rakoczy, E.P.; Katz, A.J.; et al. Pericytes derived from adipose-derived stem cells protect against retinal vasculopathy. PLoS ONE 2013, 8, e65691. [Google Scholar] [CrossRef]
  126. Giralt, M.; Villarroya, F. White, brown, beige/brite: Different adipose cells for different functions? Endocrinology 2013, 154, 2992–3000. [Google Scholar] [CrossRef] [PubMed]
Figure 1. A schematic illustration depicts the location of pericytes within the adipose tissue niche. Adipose tissue is well vascularized, with pericytes surrounding blood vessels. Notably, pericytes are embedded within the shared basement membrane alongside endothelial cells.
Figure 1. A schematic illustration depicts the location of pericytes within the adipose tissue niche. Adipose tissue is well vascularized, with pericytes surrounding blood vessels. Notably, pericytes are embedded within the shared basement membrane alongside endothelial cells.
Genes 15 00126 g001
Figure 2. Representative schematic of the white adipose tissue microenvironment, including beige adipocytes surrounding blood vessels, pericytes, immune cells, and neurons in the stromal vascular fraction.
Figure 2. Representative schematic of the white adipose tissue microenvironment, including beige adipocytes surrounding blood vessels, pericytes, immune cells, and neurons in the stromal vascular fraction.
Genes 15 00126 g002
Table 1. Overview of molecular markers for pericytes in adipose tissues.
Table 1. Overview of molecular markers for pericytes in adipose tissues.
MarkerLocationFunction in Adipose TissueConditionSpecieReferences
PDGFRβGonadal WATContribute to gonadal WAT
expansion
High-fat dieMouseVishvanath et al. [14]
Inguinal WATContribute to beige adipocytes
formation
Cold exposureMouseVishvanath et al. [14]
All BAT depotsLabel brown adipocytes in early postnatal stage, but not in
adulthood
Different
developmental stages
MouseShi et al. [15]
NG2 (CSPG4)Subcutaneous and periscapular WATTrace to 100% white adipocytesRoom temperatureMouseBerry et al. [23]
Jiang et al. [47]
Subcutaneous and perigonadal WATTrack 50% of the UCP1+ beige cellsCold exposureMouseBerry et al. [23]
TBX18Perigonadal and
inguinal WAT
No contribution to white adipocytesHigh-fat diet or
normal chow diet;
β3-adrenergic receptor agonist treatment
MouseCattaneo et al. [48]
Supraclavicular,
thoracic perivascular and perirenal BAT
Act as progenitors of brown
adipocytes in a depot-specific manner
Different
developmental stages
MouseShi et al. [15]
α-SMASubcutaneous and visceral WATNo contribution to white adipocytesRoom temperatureMouseBerry et al. [23]
Inguinal and perigonadal WATTrace to 55–68% of beige adipocytesCold exposureMouse
NestinDermal WATPotentially become adipocytes or
profibrotic cells
Ex vivoMouse cellIwayama et al. [24]
CD146Human liposuction specimensPrefer to differentiate into adipocytes over osteogenic cellsEx vivoHuman
cell
Xu et al. [49]
Hsu et al. [50]
Table 2. Brief summary of pericyte functions.
Table 2. Brief summary of pericyte functions.
FunctionBrief DescriptionReferences
Vasculature
integrity
Envelop endothelial cells;
Secrete extracellular matrix proteins;
Provide structural support to blood vessels.
Nwadozi et al. [81], Armulik et al. [82], Holm et al. [83], Birbrair et al. [84],
and Andreeva et al. [85]
AngiogenesisDetermine the location of sprout formation;
Support the angiogenic sprouting process;
Coordinate with the adjacent endothelial cells and promote angiogenesis.
Nehls et al. [86], Ponce et al. [87]
Eilken et al. [88] and
J. Gonzalez-Rubio et al. [89]
Capillary
blood flow
Regulate vascular diameter and blood flow;
Modulate blood vessel contraction and relaxation.
Rucker et al. [90], Nelson et al. [91]
and Ivanova et al. [92]
Stemness
property
Possess self-renewal and differentiation capacity;
Contribute to adipose tissue plasticity, angiogenesis, neovascularization, and osteogenesis;
Give rise to white, brown and beige adipocytes.
Mendez-Ferrer [25], Crisan et al. [93], Hoshino et al. [94], Passman et al. [95], Corselli et al. [96], Pierantozzi et al. [97],
Rodeheffer et al. [98], Farrington-Rock et al. [99], Lin et al. [100], Cai et al. [101],
Lauvrud et al. [102], James et al. [103]
Wang et al. [104], Berry et al. [23];
Jiang et al. [47], Cattaneo et al. [48]
and Shao et al. [105]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Picoli, C.d.C.; Birbrair, A.; Li, Z. Pericytes as the Orchestrators of Vasculature and Adipogenesis. Genes 2024, 15, 126. https://doi.org/10.3390/genes15010126

AMA Style

Picoli CdC, Birbrair A, Li Z. Pericytes as the Orchestrators of Vasculature and Adipogenesis. Genes. 2024; 15(1):126. https://doi.org/10.3390/genes15010126

Chicago/Turabian Style

Picoli, Caroline de Carvalho, Alexander Birbrair, and Ziru Li. 2024. "Pericytes as the Orchestrators of Vasculature and Adipogenesis" Genes 15, no. 1: 126. https://doi.org/10.3390/genes15010126

APA Style

Picoli, C. d. C., Birbrair, A., & Li, Z. (2024). Pericytes as the Orchestrators of Vasculature and Adipogenesis. Genes, 15(1), 126. https://doi.org/10.3390/genes15010126

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop